Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-09-24
1994-12-06
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 9, 514 10, 544 73, 544102, A61K 31535, C07D26538, C07D41306
Patent
active
053710819
ABSTRACT:
Disclosed are compounds useful in potentiating the cytotoxic effect of chemotherapeutic agents, the compounds having the formula: ##STR1## and pharmacologically acceptable salts thereof, wherein R is --H or --[C(O)].sub.a --(CH.sub.2).sub.b --A, a is 0-1 and b is 0-6 provided that a and b are not both zero; and A is selected from the group consisting of
REFERENCES:
patent: 4562176 (1985-12-01), Sengupta
patent: 4590277 (1986-05-01), Atwell et al.
patent: 4680382 (1987-07-01), Sengupta
Drug Evaluations, 6th ed., (1986), American Medical Assn., pp. 1081, 1171-1179, 1200-1201, 1204, 1207, 1218.
The Merck Index, 11th ed., (1989), Merck & Co., Inc., p. 445.
Thimmaiah et al., CA115:197724m (1990).
Suzuki et al, CA 83:193345m (1975).
Gal et al, CA 60:1738e-g (1963).
Samolovova et al, CA 55:23540i (1961).
Sen et al, CA 56:8711b (1961).
Antoni, CA 60:8023a (1963).
Caldwell, CA 53:17155c (1959).
Frangatos et al, CA 54:21103c (1960).
Shirley et al., CA 57:8567d (1961).
Vanderhaeghe et al, CA 56:10137g (1961).
Yarmukhametova et al, CA 84:4884y (1975) and CA 92:64849 (1979).
Ford et al., "Structural Features Determining Activity of Phenothiazines and Related Drugs for Inhibition of Cell Growth and Reversal of Multidrug Resistance", Molecular Pharmacology, 35:105-115 (1988).
Aklyama et al., "Circumvention of Multiple-Drug Resistance in Human Cancer Cells by Thioridazine, Trifluoperazine, and Chlorpromazine", JNCL, vol. 76, No. 5, May 1986, pp. 839-844.
Tsuruo et al., "Increased Accumulation of Vincristine and Adriamycin in Drug-risistance P388 Tumor Cells Following Incubation with Calcium Antagonists and Calmodulin Inhibitors", Cancer Research, 42, pp. 4730-4733, Nov. 1982.
Zamora et al., "Physical-Chemical Properties Shared by Compunds that Modulate Multidrug Resistance in Human Leukemic Cells", Molecular Pharmacology, 33:454-462 (1988).
Kessel et al., "Promotion of Daunorubicin Uptake and Toxicity by the Calcium Antagonist Tiapamil and Its Analogs", Cancer Treatment Reports, vol. 69, No. 6, Jun. 1985, pp. 673-676.
Shiraishi et al., "Lysosomotropic Agents Reverse Multiple Drug Resistance in Human Cancer Cells", Cancer Letters, 30 (1986) pp. 251-259.
Yamaguchi et al., "Overcoming Drug Resistance in Cancer Cells with Synthetic Isoprenoids", JNCL, vol. 76, No. 5, May 1986, pp. 947-953.
Sloviter, "Halogenated Benzophenoxazine Dyes", [Contribution from the Harrison Department of Surgical Research, School of Medicine, University of Pennsylvania, and the Department of Neurosurgery, Hospital of the University of Pennsylvania], vol. 71, pp. 3360-3362, J. Amer. Chem. Soc. (1949).
Crossley et al., "Chemotherapeutic Dyes. I. 5-Aralkylamino-9-alkylaminobenzo[a]phenoxazines", Journal of the American Chemical Society, vol. 74, Feb. 5, 1952, No. 3, pp. 573-586.
Sen et al., "Potential Carcinostatic Derivatives of Benzo[a]- and Benzo[b]phenoxazine", [Contribution from the Department of Chemistry, the University of Tennessee], Oct. 1961, pp. 3861-3863, J. Org. Chem.
Sen et al., "Syntheses of 5-[4-{N,N-Bis(2-chloroethyl)amino}benzylamino]-9-N,N-dialkyl-aminobenzo[a] phenoxazonium Chlorides", Indian Journal of Chemistry, vol. 21B, Jul. 1982, pp. 642-645.
Cincotta et al., "Novel Red Absorbing Benzo[a]phenoxazinium and Benzo[s]phenothiazinium Photosensitizers: In Vitro Evaluation", Photochemistry and Photobiology, vol. 46, No. 5, pp. 751-758, 1987.
Jain et al., "Potential Anticancer Agents: Synthesis of Amides & Esters of 2-Amino-4,6-dimethyl-3-oxophenoxazine-I,9-dicarboxylic Acid", Indian Journal of Chemistry, vol. 15B, Feb. 1977, pp. 163-164.
Palmer et al., "Potential Antitumor Agents. 54. Chromophore Requirements for In Vivo Antitumor Activity Among the General Class of Linear Tricyclic Carboxamides", J. Med. Chem., 1988, 31, pp. 707-712.
Sengupta et al., "`Reverse` and `Symmetrical` Analogues of Actinomycin D: Metabolic Activation and In Vitro and In Vivo Tumor Growth Inhibitory Activities", J. Med. Chem., 1985, vol. 28, No. 5, pp. 620-628.
Kanzawa, et al., "Antitumor Activity of Haloacetylcarbazole Derivatives", Gann, The Japanese Journal of Cancer Research, 64, pp. 391-396 (1973).
Horton Julie K.
Houghton Peter J.
Thimmaiah Kuntebommanahalli N.
Datlow Philip I.
Shah Mukund J.
St. Jude Children's Research Hospital
LandOfFree
N-substituted phenoxazines for treating multidrug resistant canc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted phenoxazines for treating multidrug resistant canc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted phenoxazines for treating multidrug resistant canc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-214606